CVS HEALTH Corp (CVS) stock
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 19/3031% below fair value
$89.79+0.27 (+0.30%)
Close on Nov 12, 2026Market cap $114.84BP/E 10.5Yield 2.96%
Cvs Health gross margin
Gross margin is gross profit as a percentage of revenue.
Cvs Health's gross margin for the twelve months ending Sep 30, 2026 was 44.2%. For fiscal 2025 it was 45.0%, against 44.7% the year before. The highest annual figure on record is 45.0% in fiscal 2025.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 45.0% | +0.3 |
| FY2024 | Dec 31, 2024 | 44.7% | +5.3 |
| FY2023 | Dec 31, 2023 | 39.3% | +0.4 |
| FY2022 | Dec 31, 2022 | 38.9% | −0.9 |
| FY2021 | Dec 31, 2021 | 39.8% | +0.8 |
| FY2020 | Dec 31, 2020 | 39.0% | +0.8 |
| FY2019 | Dec 31, 2019 | 38.2% | +18.6 |
| FY2018 | Dec 31, 2018 | 19.6% | +4.1 |
| FY2017 | Dec 31, 2017 | 15.4% | −0.8 |
| FY2016 | Dec 31, 2016 | 16.3% | −1.1 |
| FY2015 | Dec 31, 2015 | 17.3% | −0.9 |
| FY2014 | Dec 31, 2014 | 18.2% | −0.6 |
| FY2013 | Dec 31, 2013 | 18.8% | +0.5 |
| FY2012 | Dec 31, 2012 | 18.3% | −0.9 |
| FY2011 | Dec 31, 2011 | 19.2% | −1.9 |
| FY2010 | Dec 31, 2010 | 21.1% | +0.4 |
| FY2009 | Dec 31, 2009 | 20.7% | −0.2 |
| FY2008 | Dec 31, 2008 | 20.9% | −0.2 |
| FY2007 | Dec 29, 2007 | 21.1% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 43.6% | −1.0 |
| Q2 FY2026 | Jun 30, 2026 | 44.5% | −0.9 |
| Q1 FY2026 | Mar 31, 2026 | 44.8% | −1.2 |
| Q4 FY2025 | Dec 31, 2025 | 44.1% | +0.7 |
| Q3 FY2025 | Sep 30, 2025 | 44.5% | +0.0 |
| Q2 FY2025 | Jun 30, 2025 | 45.4% | +0.2 |
| Q1 FY2025 | Mar 31, 2025 | 46.0% | +0.4 |
| Q4 FY2024 | Dec 31, 2024 | 43.4% | +4.6 |
| Q3 FY2024 | Sep 30, 2024 | 44.5% | +5.4 |
| Q2 FY2024 | Jun 30, 2024 | 45.2% | +5.4 |
| Q1 FY2024 | Mar 31, 2024 | 45.6% | +6.0 |
| Q4 FY2023 | Dec 31, 2023 | 38.8% | +0.5 |
| Q3 FY2023 | Sep 30, 2023 | 39.1% | +1.1 |
| Q2 FY2023 | Jun 30, 2023 | 39.8% | +0.9 |
| Q1 FY2023 | Mar 31, 2023 | 39.7% | −1.1 |
| Q4 FY2022 | Dec 31, 2022 | 38.3% | −1.2 |
| Q3 FY2022 | Sep 30, 2022 | 37.9% | −1.1 |
| Q2 FY2022 | Jun 30, 2022 | 38.9% | −1.2 |
| Q1 FY2022 | Mar 31, 2022 | 40.8% | −0.1 |
| Q4 FY2021 | Dec 31, 2021 | 39.5% | +0.5 |
| Q3 FY2021 | Sep 30, 2021 | 39.0% | +0.1 |
| Q2 FY2021 | Jun 30, 2021 | 40.1% | +1.7 |
| Q1 FY2021 | Mar 31, 2021 | 40.8% | +1.3 |
| Q4 FY2020 | Dec 31, 2020 | 39.0% | +1.9 |
| Q3 FY2020 | Sep 30, 2020 | 38.9% | +1.3 |
| Q2 FY2020 | Jun 30, 2020 | 38.4% | −0.2 |
| Q1 FY2020 | Mar 31, 2020 | 39.6% | −0.0 |
| Q4 FY2019 | Dec 31, 2019 | 37.1% | +11.6 |
| Q3 FY2019 | Sep 30, 2019 | 37.6% | +22.2 |
| Q2 FY2019 | Jun 30, 2019 | 38.6% | +23.2 |
| Q1 FY2019 | Mar 31, 2019 | 39.6% | +24.6 |
| Q4 FY2018 | Dec 31, 2018 | 25.5% | +9.1 |
| Q3 FY2018 | Sep 30, 2018 | 15.4% | +0.0 |
| Q2 FY2018 | Jun 30, 2018 | 15.3% | +0.2 |
| Q1 FY2018 | Mar 31, 2018 | 15.0% | +0.2 |
| Q4 FY2017 | Dec 31, 2017 | 16.3% | −0.2 |
| Q3 FY2017 | Sep 30, 2017 | 15.4% | – |
| Q2 FY2017 | Jun 30, 2017 | 15.2% | – |
| Q1 FY2017 | Mar 31, 2017 | 14.8% | – |
| Q4 FY2016 | Dec 31, 2016 | 16.5% | – |
See a number that looks wrong?